Investor preview environment · No accounts, no logins, no stored sessions · Inputs are never persisted, never seen by the team
Evely · The decision layer for women's health

A live look
at what we're
building for women.

Two working tools, calibrated to female biology — Blueprint synthesizes symptoms into priorities, Supplement Advisor cuts the noise from your stack. Click in. Try it with your own context. Nothing is saved.

Cohort
3now in pilot
Tools live
2of 6 planned
Built for
Femalebiology & life-stage
Round
Seedextension · open
Pilot n
1.5kwomen, 2 cohorts
Geo
US · EUcohort 3 live

"Evely identified my symptom pattern — weirdly accurate — and gave me a clear focus area."

Sarah, 41 · Pilot cohort

The toolkit, hands-on.

02 / Live demos
Live demo

Blueprint
— your priorities.

Three minutes of symptom + life-stage check-in. Out comes a ranked plan: top three drivers to focus on, and what to safely ignore for now.

1
Sleep architecture
Cortisol curve · 3am wake-ups
2
Estrogen rhythm
Cycle irregularity · perimeno markers
3
Glucose stability
Watch · not urgent
68
Pattern signal
blueprint.evely.health/pro Nothing saved
Live demo

Supplement
Advisor — cut the stack.

Drop in what you're already taking. We tell you what's likely working, what's redundant, and what's missing — calibrated to your symptoms and life stage.

Magnesium glycinate
Keep
Multivitamin (generic)
Cut
Vitamin D3 + K2
Add
supplementintelligence.evely.health Nothing saved

Play freely.
Nothing follows you out.

These are the production tools — same models, same logic — running in a sandboxed investor environment. We don't want you holding back, so we built it so you can't be held to anything.

01

No accounts. No emails.

You don't sign in. The tools accept input directly without identifying you in any way.

02

Sessions evaporate.

Inputs and outputs are processed in-memory and discarded when you close the tab. Nothing is written to a database.

03

The team never sees it.

No logs of what you typed. No replay. Try your own symptoms, your spouse's, a stress-test edge case — none of it reaches us.

04

Same tools, same models.

This isn't a stripped demo. You're using exactly what cohort members use — minus the personalization that comes from a saved profile.

Pilot signal · Cohorts 1–2

What the
data already shows.

Across 1,500+ women in our first cohorts, Evely's prioritization layer reliably moved people off generic checklists and onto a focused first move. These are aggregate, anonymized pilot numbers — not projections.

Felt clearer in 4 weeks
Self-reported "I know where to start" score
82%
Reduced supplement spend
Median monthly spend after Supplement Advisor review
−47%
Pattern match accuracy
Symptom cluster vs. clinician chart review
91%
Weekly active in cohort
Returned for the weekly check-in loop
73%
n = 1,500+ · Cohorts 1–2 · Pilot data, Jan–Mar 2026 · Available on request under NDA
The science layer

Built with
scientific rigour.

Every priority Evely surfaces is grounded in peer-reviewed research on female endocrinology, sleep, and metabolic health — translated into a model that respects life stage, cycle phase, and individual context.

Prof. Nilah Ioannidis

Prof. Nilah Ioannidis

Chief Scientific Advisor
CurrentlyUC Berkeley
PreviouslyStanford · Harvard · Cambridge
FocusPrecision health · Genomics · Longevity
Publications46 peer-reviewed
Prof. Alexander Ioannidis

Prof. Alexander Ioannidis

Scientific Advisor
CurrentlyStanford University
PreviouslyHarvard · Cambridge
FocusPrecision genetics · Clinical AI
Publications81 peer-reviewed
Research lineage
Stanford Harvard UC Berkeley Cambridge
What's next

The toolkit,
twelve months out.

Two tools live today. Four more are on the path — each one stays inside the same decision-layer thesis: less noise, more direction, calibrated to female biology at every life stage.

01
Blueprint
Symptom + life-stage check-in → ranked priorities and what to ignore for now.
Live
02
Supplement Advisor
Audit the stack — keep, cut, add — based on symptoms, labs, and interactions.
Live
03
Cycle Lens
Reads cycle-phase signals from wearables to recalibrate priorities week-to-week.
In beta · Q2
04
Lab Translator
Plain-language reading of bloodwork through a female-biology lens. Catches what "normal" misses.
Q3 2026
05
Perimeno Compass
A dedicated module for the 35–55 transition — protocols, escalation flags, clinician handoff.
Q3 2026
06
Clinician Bridge
A printable summary your doctor will actually read — pattern, priorities, and asks.
Q4 2026
Round open · Seed extension

We're building the
decision layer for the
half of medicine that's been ignored.

If what you saw resonates, we'd love to talk. Founders are taking 30-minute conversations with aligned investors through May.

Stage: Seed extension Geo: US + EU Lead: Considering Close: Q3 2026
Blueprint
Spinning up your private session…
Booting sandbox · No session ID assigned